Thu, June 2, 2022
Wed, June 1, 2022
Tue, May 31, 2022
Mon, May 30, 2022
Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022

Andrew Berens Maintained (ZYME) at Buy with Increased Target to $19 on, May 27th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-19-on-may-27th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Berens of SVB Leerink, Maintained "Zymeworks Inc." (ZYME) at Buy with Increased Target from $18 to $19 on, May 27th, 2022.

Andrew has made no other calls on ZYME in the last 4 months.



There are 5 other peers that have a rating on ZYME. Out of the 5 peers that are also analyzing ZYME, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Andrew


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $40 on, Monday, May 23rd, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $28 on, Monday, May 9th, 2022
  • Charles Zhu of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $14 on, Thursday, May 5th, 2022
  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $15 on, Tuesday, March 15th, 2022
  • Jim Birchenough of "Wells Fargo" Maintained at Buy with Decreased Target to $48 on, Wednesday, February 9th, 2022

Publication Contributing Sources